Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia. (Q37576591)
Jump to navigation
Jump to search
scientific article published on 06 February 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia. |
scientific article published on 06 February 2013 |
Statements
Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia (English)
S E M Herman
D Liu
A Wiestner
6 February 2013